This offering was not bought by legit institutions. They probably short sold all the shares at $0.90-1.00 prior to offering. Then bought the offering to cover. Now they probably only hold warrants.
I have to admit when PSEC had many, many detractors. it looked pretty bleak. Glad I held through. FSC has however been a real dog that I wish I did not own. Luckily I own much more PSEC. Why did PSEC rebound and FSC not? I think it comes down to PSEC is a better managed company and the guys at helm knew how to right the ship. I stay away from BDCs for the most part now but the one I really think is worth its weight is GAIN.
Yeah he better make sure not to drop the soap... All in all I think he is looking forward to being someone's bltch.
I agree that ORR is important. But if you look at clinical trials website it does not list ORR as an endpoint.